Let’s see…
Psilocybin is a naturally occurring compound, so there is no value to be gained by Novatis, Pfizer, Roche (et. al.) in patenting it.
I predict that psilocybin therapy will be killed in regulatus utero by the above named companies who would force depressed people to pay more for less effective (yet patentable) medications, rather than permitting a more effective therapy (that they can’t profit from) come to market.
